Hikaru Sugimoto Selected Research

Hikaru Sugimoto Research Topics

Disease

27	Neoplasms (Cancer) 11/2023 - 04/2003
8	Fibrosis (Cirrhosis) 09/2015 - 07/2007
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 11/2015
6	Neoplasm Metastasis (Metastasis) 12/2018 - 09/2011
5	Kidney Diseases (Kidney Disease) 01/2021 - 08/2002
5	Inflammation (Inflammations) 01/2018 - 07/2007
5	Proteinuria 04/2007 - 11/2002
4	Hereditary Nephritis (Alport Syndrome) 06/2024 - 04/2005
4	Carcinoma (Carcinomatosis) 01/2022 - 12/2006
4	Pre-Eclampsia (Preeclampsia) 11/2018 - 04/2003
3	Adenocarcinoma 01/2022 - 11/2015
3	Renal Insufficiency (Renal Failure) 06/2021 - 07/2005
3	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2014
3	Hypoxia (Hypoxemia) 01/2020 - 10/2005
3	Carcinogenesis 10/2018 - 06/2011
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2008 - 09/2002
2	Insulin Resistance 04/2024 - 11/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2023
2	Hypertension (High Blood Pressure) 08/2022 - 11/2018
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 06/2021 - 01/2021
2	Nephritis 06/2021 - 11/2002
2	Diabetes Complications 01/2011 - 07/2007
2	Leukemia 02/2009 - 02/2005
2	Glomerulonephritis 03/2008 - 11/2002
1	Glucose Intolerance 11/2023
1	Pancreatitis 03/2023
1	Cognitive Dysfunction 01/2023
1	Dementia (Dementias) 01/2023
1	Wounds and Injuries (Trauma) 01/2022
1	Osteogenesis Imperfecta (Lobstein Disease) 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021

Drug/Important Bio-Agent (IBA)

7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 04/2003
7	type IV collagen alpha3 chain (Goodpasture antigen)IBA 06/2011 - 04/2003
6	CollagenIBA 01/2022 - 06/2003
6	Proteins (Proteins, Gene)FDA Link 05/2014 - 04/2003
6	Collagen Type IV (Type IV Collagen)IBA 11/2009 - 04/2005
5	Collagen Type I (Type I Collagen)IBA 01/2022 - 12/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 06/2008
4	IntegrinsIBA 01/2022 - 06/2003
4	EndostatinsIBA 06/2011 - 04/2003
4	Angiogenesis InhibitorsIBA 06/2011 - 03/2004
4	acetoxycycloheximideIBA 02/2009 - 02/2005
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2020
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2022
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2018 - 02/2005
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018 - 06/2010
3	AntibodiesIBA 02/2013 - 04/2003
3	Peptides (Polypeptides)IBA 02/2012 - 09/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2011 - 07/2007
2	Insulin (Novolin)FDA Link 04/2024 - 11/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2013
2	Indicators and Reagents (Reagents)IBA 08/2022 - 12/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2021 - 01/2021
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 11/2018 - 06/2008
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2017
2	Angiopoietin-2IBA 12/2016 - 02/2015
2	Gemcitabine FDA Link 11/2015 - 06/2014
2	Protein Synthesis InhibitorsIBA 02/2009 - 06/2008
2	Caspase 8 (Caspase-8)IBA 02/2009 - 04/2008
2	Integrin alpha1IBA 11/2008 - 10/2005
2	Integrin alphaVbeta3IBA 09/2008 - 02/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2008 - 04/2003
2	NF-kappa B (NF-kB)IBA 06/2008 - 04/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 04/2008
2	nephrinIBA 04/2007 - 04/2003
2	Thrombospondin 1IBA 02/2005 - 03/2004
2	Matrix Metalloproteinases (MMPs)IBA 03/2004 - 06/2003
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024
1	dapagliflozinIBA 04/2024
1	Glucagon (Glukagon)FDA Link 04/2024
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	Death Domain ReceptorsIBA 11/2023
1	AntigensIBA 03/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2023
1	KRASG12D inhibitor MRTX1133IBA 02/2023
1	InterleukinsIBA 12/2022
1	Small Nuclear RNA (snRNA)IBA 12/2022
1	Estrogen ReceptorsIBA 12/2022
1	Antihypertensive Agents (Antihypertensives)IBA 08/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	alpha2 Subunit Collagen Type IIBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 06/2021
1	SteroidsIBA 06/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	mizoribineIBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	GlycogenIBA 11/2018
1	Prostaglandins FIBA 11/2018

Therapy/Procedure

12	Therapeutics 06/2024 - 11/2002
2	Immunotherapy 03/2023 - 06/2014
2	Drug Therapy (Chemotherapy) 12/2016 - 11/2015
2	Transplantation 11/2009 - 05/2006
1	Brain-Computer Interfaces 01/2023